August Bioservices Continues Growth with $65M Series B Raise

Nashville-based August Bioservices, a pharmaceutical contract development and manufacturing organization (CDMO) providing drug discovery, development and pharmaceutical manufacturing services, announced it secured $65 million in Series B funding on December 1.

The new funding will be used to expand August Bio’s capacity to meet the pharmaceutical manufacturing needs for customers of all sizes. Specifically, this expansion will add incremental capacity for production of large batches and allow the company to fully automate downstream inspection, labeling and packaging processes in support of the increased throughput.

Read more at the Nashville Business Journal.